The trial concluded that AOD-9604 did not induce significant weight loss, leading to a halt in the development of the drug as a weight-loss solution
Additionally, as the first CVD to develop in patients with diabetes is often heart failure rather than myocardial infarction [1], it is becoming clear that the pathology of diabetes itself causes heart failure through direct effects on cardiomyocytes and other myocardial cell types
Prescription and access : GLP-1 receptor agonists are prescription-only medications available through NHS diabetes services when clinically indicated according to NICE criteria
Regular clinical assessment can determine whether B12 therapy remains appropriate rather than focusing solely on serum levels
The increasing urbanization and more sedentary lifestyle combined with the poor dietary habits lead to the expansion of patient population
Abdel-Azid MT, Abdou MS, Soliman K, and et al